• home
• organisatie
• onderzoeksgroepen
• klinische partners
• publicaties
• contacteer ons
• zoek
• IBB steunen
• geschiedenis
• links
• lab only

Publicaties

IBB
Scientific Report 2008 (ingekorte versie)	pdf
Lijst van publicaties IBB in 2007
Aalten P., F.R. Verhey, M. Boziki, R. Bullock, E.J. Byrne, V. Camus, M. Caputo, D. Collins, P.P. De Deyn, K. Elina, G. Frisoni, N. Girtler, C. Holmes, C. Hurt, A. Marriott, P. Mecocci, F. Nobili, P.J. Ousset, E. Reynish, E. Salmon, M. Tsolaki, B. Vellas, P.H. Robert. Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consorium: Part I. Dement. Geriatr. Cogn. Disord. 24 (6): 457-463 (2007). (IF = 2.511)
Aarsland D., K. Bronninck, U. Ehrt, P.P. De Deyn, S. Tekin, M. Emre, J.L. Cummings. Neuropsychiatric symptoms in patients with PD and dementia: Frequency, profile and associated caregiver stress. J. Neurol. Neurosurg. Psychiatry 78 (1): 36-42 (2007). (IF = 3.630)
Abrahantes J.C., Aerts M., van Everbroeck B., Saegerman C., Berkvens D., Geys H., Mintiens K., Roels S., Cras P., Classification of sporadic Creutzfeldt-Jakob disease based on clinical and neuropathological characteristics. Eur. J. Epidemiol. 22 (7): 457-65 (2007). (IF = 1.605)
Baar I., Jacobs B.C., Govers N., Jorens P.G., Parizel P.M., Cras P., Campylobacter jejuni-induced acute transverse myelitis. Spinal Cord. 45 (10): 690-4 (2007). (IF = 1.791)
Baillieux H., F. Weyns, P. Paquier, P.P. De Deyn, P. Mariën. Posterior fossa syndrome after a vermian stroke: a new case of the literature. Pediatr. Neurosurg. 43 (5): 386-395 (2007). (IF = 0.972)
Bogaerts V., S. Engelborghs, S. Kumar-Singh, D. Goossens, B. Pickut, J. van der Zee, K. Sleegers, K. Peeters, J.-J. Martin, J. Del-Favero, T. Gasser, D.W. Dickson, Z.K. Wszolek, P.P. De Deyn, J. Theuns, C. Van Broeckhoven. A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder. Brain 130: 2277-2291 (2007). (IF = 7.617)
Bogaerts, V., Theuns, J., Van Broeckhoven, C. Genetic findings in Parkinson's disease and their translation towards treatment: a leading part for mitochondria? Genes Brain and Behavior (2007)(Epub ahead) (IF = 4.385)
Brouns R., R. Sheorajpanday, E. Braxel, F. Eyskens, R. Baker, D. Hughes, A. Mehta, T. Timmerman, M.-F. Vincent, P.P. De Deyn. Middelheim Fabry Study (MiFaS): A retrospective Belgian study on the prevalence of Fabry disease in young patiens with cryptogenic stroke. Clin. Neurol. Neurosurg. 109: 479-484 (2007). (IF = 1.506)
Brouwers N., K. Nuytemans, J. van der Zee, I. Gijselinck, S. Engelborghs, J. Theuns, S. Kumar-Singh, B.A. Pickut, P. Pals, B. Dermaut, V. Bogaerts, T. De Pooter, S. Serneels, M. Van den Broeck, I. Cuijt, M. Mattheijssens, K. Peeters, R. Sciot, J.J. Martin, P. Cras, P. Santens, R. Vandenberghe, P.P. De Deyn, M. Cruts, C. Van Broeckhoven, K. Sleegers. Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family. Arch. Neurol. 64 (10): 1436-1446 (2007). (IF = 5.204)
Cannon R.C., Gewaltig M.O., Gleeson P., Bhalla U.S., Cornelis H., Hines M.L., Howell F.W., Muller E., Stiles J.R., Wils S., De Schutter E., Interoperability of neuroscience modeling software: current status and future directions. (Review) Neuroinformatics 5 (2): 127-38 (2007). (IF = 3.541)
Cohen G., G. Glorieux, P. Thornalley, E. Schepers, N. Meert, J. Jankowski, V. Jankowski, A. Argiles, B. Anderstam, P. Brunet, C. Cerini, L. Dou, R. Deppisch, B. Marescau, Z. Massy, A. Perna, J. Raupachova, M. Rodriguez, B. Stegmayr, R. Vanholder, W.H. Hörl for the European Uremic Toxin Work Group (EUTox). Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro - towards a standardized approach for research on uraemia. Nephrol. Dial. Transplant. 22: 3381-3390 (2007). (IF = 3.154)
Cornelis H., De Schutter E., Neurospaces: towards automated model partitioning for parallel computers. Neurocomputing: an international journal 70 (10/12): 2117-2121 (2007). (IF = 0.860)
De Bleecker JL, Paepe BD, Vervaet VL, Arys B, Creus KK, Werbrouck BF, Martin JJ. (2007) Distribution of glucocorticoid receptor alpha and beta subtypes in the idiopathic inflammatory myopathies. Neuromuscular Disorders 17:186-193. (IF = 2.615)
De Schutter E., Neuroscience leading the way: reviews cascade by the INCF. Neuroinformatics 5 (4): 205-6 (2007) (IF = 3.541)
De Smet H.J., H. Baillieux, C. Catsman-Berrevoets, P.P. De Deyn, P. Mariën, P.F. Paquier. Postoperative motor speech production in children with the syndrome of ´cerebellar´ mutism and subsequent dysarthria: A critiacal review of literature. Eur. J. Paediatr. Neurol. 11: 193-207 (2007 ). (IF = 1.364)
De Smet H.J., H. Baillieux, P.P. De Deyn, P. Mariën, P. Paquier. The cerebellum and language: The story so far. Folia Phoniatr. Logop. 59: 165-170 (2007). (IF = 0.655)
Dierckx E., Engelborghs S., De Raedt R., De Deyn P.P., Ponjaert-Kristoffersen I. Differentiation between dementia and depression among older persons: can the difference between actual and premorbid intelligence be useful? Journal of Geriatric Psychiatry and Neurology. In druk (IF = 1.970)
Dierckx E., S. Engelborghs, R. De Raedt, P.P. De Deyn, I. Ponjaert-Kristoffersen. Mild cognitive impairment: What´s in a name? Gerontology 53: 28-35 (2007). (IF = 1.439)
Dierckx E., S. Engelborghs, R. De Raedt, P.P. De Deyn, I. Ponjaert-Kristoffersen. Differentiation between mild cognitive impairment, Alzheimer´s disease and depression by means of cued recall. Psychol. Med. 37 (5): 747-55 (2007). (IF = 3.816)
Dierick, I., Irobi, J., Janssens, S., Theuns, J., Lemmens, R., Jacobs, A., Corsmit, E., Hersmus, N., Van Den Bosch, L., Robberecht, W., De Jonghe, P., Van Broeckhoven, C., Timmerman, V. (2007) Genetic variant in the HSPB1 promoter region impairs the HSP27 stress response. Human Mutation, 28: 830 (IF = 6.473)
Ehrt U., K. Broninck, P.P. De Deyn, M. Emre, S. Tekin, R. Lane, D. Aarsland. Subtreshold depression in patients with Parkinson´s disease and dementia - clinical and demographic correlates. Int. J. Geriatr. Psychiatry 22: 980-983 (2007). (IF = 1.930)
Eloot S., A. Torremans, R. De Smet, B. Marescau, P.P. De Deyn, P. Verdonck, R. Vanholder. Complex compartmental behavior of small water-soluble uremic retention solutes: Evaluation by direct measurements in plasma and erythrocytes. Am. J. Kidney Dis. 50 (2): 279-288 (2007). (IF = 4.072)
Engelborghs S., K. De Vreese, T. Van de Casteele, H. Vanderstichele, B. Van Everbroeck, P. Cras, J.-J. Martin, E. Vanmechelen, P.P. De Deyn. Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia. Neurobiol. Aging 2007, Apr 9; (Epub ahead of print). (IF = 5.599)
Engelborghs S., K. Sleegers, P. Cras, N. Brouwers, S. Serneels, E. De Leenheir, J.J. Martin, E. Vanmechelen, C. Van Broeckhoven, P.P. De Deyn. No association of CSF biomarkers with APOE (varepsilon) 4, plaque and tangle burden in definite Alzheimer´s disease. Brain 130: 2320-2326 (2007). (IF = 7.617)
Engelborghs S., Vloeberghs E., Le Bastard N., Van Buggenhout M., Mariën P., Somers N., Nagels G., Pickut B.A., De Deyn P.P. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia. Neurochemistry International. Epub nov 2007. (IF = 3.159)
Errijgers V., D. Van Dam, I. Gantois, C.J. Van Ginneken, A.W. Grossman, R. D´Hooge, P.P. De Deyn, , R.F. Kooy. FVBS/.129P2-Pde6b(+) Tyr (c-ch)/Ant, a sighted variant of the FVB/N strain suitable for behavioral analysis. Genes Brain Behav. 6 (6): 552-557 (2007). (IF = 4.385)
Gebruers N., S. Truijen, S. Engelborghs, P.P. De Deyn. Volumetric evaluation of upper extremities in 250 healthy persons. Clin. Physiol. Funct. Imaging 27: 17-22 (2007). (IF = 0.938)
Gijselinck, I., Sleegers, K., Engelborghs, S., Robberecht,W., Martin, J-J., Vandenberghe, R., Sciot,R., Dermaut, B., Goossens, D., van der Zee, J., De Pooter, T., Del-Favero, J., Santens, P., De Jonghe, P., De Deyn, P., Van Broeckhoven, C., Cruts, M.: Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS. Neurobiology of Aging Dec 2007). (IF = 5.599)
Hakonen, A.H., Davidzon, G., Salemi, R., Bindoff, L.A., Van Goethem, G., Dimauro, S., Thorburn, D.R, Suomalainen, A. (2007) Abundance of the POLG disease mutations in Europe, Australia, New Zealand, and the United States explained by single ancient European founders. European Journal of Human Genetics, 15: 779-783 (IF = 3.697)
Hauser R.A., O. Rascol, A. Dkorczyn, A. Jon Stoessl, R. L. Watts, W. Poewe, P.P. De Deyn. Ten-year follow-up of Parkinson´s disease patients randomized to initial therapy with ropinirole or levodopa. Mov. Disord. 22 (16): 2409-2417 (2007). (IF = 3.323)
Ivanova, N., Claeys, K., Deconinck, T, Litvinenko, I., Jordanova, A., Auer-Grumbach, M., Haberlova, J., Löfgren, A., Smeyers, G., Nelis, E., Mercelis, R., Plecko, B., Priller, J., Zámecník, J., Ceulemans, B., Erichsen, K., Björck, E., Nicholson, G., Sereda, M., Seeman, P., Kremensky, I., Mitev, V., De Jonghe, P. (2007) Hereditary spastic paraplegia 3A associated with axonal neuropathy. Archives of Neurology, 64: 706-713 (IF = 5.204)
Katz I., P.P. De Deyn, J. Mintzer, A. Greenspan, Y. Zhu, H. Brodaty. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer´s disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials. Int. J. Geriatr. Psychiatry 22: 475-484 (2007). (IF = 1.930)
Kumar-Singh, S., Van Broeckhoven, C. (2007) Frontotemporal lobar degeneration: Current concepts and advances. Brain Pathology, 17: 104-113 (IF = 5.274)
Le Bastard N., M. Van Buggenhout, E. De Leenheir, J.-J. Martin, P.P. De Deyn, S. Engelborghs. Low specificity limits the use of the cerebrospinal fluid A?1-42/P-tau181P ratio to discriminate Alzheimer´s disease from vascular dementia. J. Gerontol. A Biol. Sci. Med. Sci. 62 (8): 923-924 (2007). (IF = 2.861)
Lehtokari V-L, Ceuterick-de Groote C, De Jonghe P, Marttila M, Laing NG, Pelin K, Wallgren-Petterson C (2007) Cap disease caused by heterozygous deletion of the β- tropomyosin gene TPM2. Neuromuscular Disorders 17 (6) : 433-442. (IF = 2.615)
Maex R., De Schutter E., Mechanism of spontaneous and self-sustained oscillations in networks connected through axo-axonal gap junctions. Eur J. Neurosci. 25 (11): 3347-58 (2007). (IF = 3.709)
Mariën P., J. Verhoeven, R. Brouns, L. De Witte, A. Dobbeleir, P.P. De Deyn. Apraxic agraphia following a right cerebellar hemorrhage. Neurology 69 (9): 926-929 (2007). (IF = 5.690)
Miltenberger-Miltenyi G., Janecke A.R., Wanschitz J., Timmerman V., Windpassinger C., Auer-Grumbach M., Löscher W.L. (2007) Clinical and electrophysiological features in CMT with mutations in the NEFL gene. Archives of Neurology, 64: 966-970. (IF = 5.204)
Nagels G., M.B. D´hooghe, L. Vleugels, D. Kos, M. Despontin, P.P. De Deyn. P300 and treatment effect of modafinil on fatigue in multiple sclerosis. J. Clin. Neurosci. 14: 33-40 (2007). (IF = 0.673)
Nagels G., S. Engelborghs, E. Vloeberghs, W. Lemmens, B.A. Pickut, P.P. De Deyn. Correlation between actigraphy and nurses´ observation of activity in dementia. Int. J. Geriatr. Psychiatry 22: 84-86 (2007). (IF = 1.930)
Rabinowitz J., I. Katz, P.P. De Deyn, A. Greenspan, H. Brodaty. Treating behavioral and psychological symptoms in patients with psychosis of Alzheimer's disease using risperidone. Int. Psychogeriatr. 19 (2): 227-240 (2007). (IF = 1.745)
Rademakers R., Sleegers K., Pals P., Lohmann E., Durr A., Engelborghs S., De Pooter T., Van den Broeck M., Camuzat A., Nuytemans K., Pickut B., Cruts M., De Deyn P.P., Cras P., Brice A., Van Broeckhoven C. High density MAPT haplotyping in two independent Causasian PD associated samples implicates tau splicing in early-onset Parkinson's disease susceptibility. American Journal of Human Genetics, 77: 643-652 (IF = 12.629)
Scalais E, Nuttin C, Seneca S, Smet J, De Paepe B., Martin J-J, Stevens R, Pierart F, Battisti O, Lissens W, De Meirleir L, Van Coster R: Infantile presentation of the mitochondrial A8344G mutation. (2007) Letter to the Editor. European Journal of Neurology 14: e3-e5. (IF = 2.437)
Sevin C., L. Verot, A. Benraiss, D. Van Dam, G. Nagels, F. Fouquet, V. Gieselmann, M.T. Vanier, P.P. De Deyn, P. Aubourg, N. Cartier. Partial cure of established disease in an animal model of metachromatic leukodystrophy after intracerebral adeno-associated virus-mediated gene transfer. Gene Ther. 14 (5): 405-415 (2007). (IF = 4.782)
Sheorajpanday R.V.A., P.P. De Deyn. Epileptic fits and epilepsy in the elderly: General reflections, specific issues and therapeutic implications. Clin. Neurol. Neurosurg. 109: 727-743 (2007). (IF = 1.506)
Shin S.L., Hoebeek F.E., Schonewille M., De Zeeuw C.I., Aertsen A., De Schutter E., Regular patterns in cerebellar Purkinje cell simple spike trains. PLoS ONE 2 (5): e485, 1-9 (2007). (IF = --)
Shin S.L., Rotter S., Aertsen A., De Schutter E., Stochastic description of complex and simple spike firing in cerebellar Purkinje cells. Eur. J. Neurosci. 25 (3): 785-94 (2007). (IF = 3.709)
Sleegers, K., Kumar-Singh, S., Cruts, M., Van Broeckhoven, C. Molecular pathogenesis of frontotemporal lobar degeneration. Archives of Neurology (Accepted for Publication) (IF = 5.204)
Stendel, C., Roos, R., Deconinck, T, Pereira, J., Castagner, F., Niemann, A., Kirschner, J., Korinthenberg, R., Ketelsen, U-P., Battaloglu, E., Parman, Y., Nicholson, G., Ouvrier, R., Seeger, J., De Jonghe, P., Weis, J., Krüttgen, A., Rudnik-Schöneborn, S., Bergmann, C., Suter, U., Zerres, K., Timmerman, V., Relvas, J.B., Senderek, J. (2007) Peripheral nerve demyelination caused by a mutant Rho GTPase guanine nucleotide exchange factor, frabin/FGD4. American Journal of Human Genetics 81(1): 158-164 (IF = 12.629)
Steuber V., Mittmann W., Hoebeek F.E., Silver R.A., De Zeeuw C.I., Häusser M., De Schutter E., Cerebellar LTD and pattern recognition by Purkinje cells. Neuron. 54 (1): 121-36 (2007). (IF = 13.894)
Taes Y.E.C., B. Marescau, A. De Vriese, P.P. De Deyn, E. Schepers, R. Vanholder, J.R. Delanghe. Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status. Nephrol. Dial. Transplant. 2007 Nov 29 (Epub ahead of print). (IF = 3.154)
Van Dam D., K. Coen, P.P. De Deyn. Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alsheimer´s disease. Psychopharmacology 2007 Nov 16; (Epub ahead of print). (IF = 3.625)
van der Zee J., Le Ber I., S. Maurer-Stroh, S. Engelborghs, I. Gijselinck, A. Camuzat, N. Brouwers, R. Vandenberghe, K. Sleegers, D. Hannequin, B. Dermaut, J. Schymkowitz, D. Campion, P. Santens, J.J. Martin, L. Lacomblez, T. De Pooter, K. Peeters, M. Mattheijssens, M. Vercelletto, M. Van den Broeck, M. Cruts, P.P. De Deyn, F. Rousseau, A. Brice, C. Van Broeckhoven. Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia. Hum. Mutat. 28 (4): 416 (2007). (IF = 6.473)
van Diest D., van Goethem J.W.M., Vercruyssen A., Jadoul C., Cras P., Posterior reversible encephalopathy and Guillain-Barré syndrome in a single patient: coincidence or causative relation? Clinical neurology and neurosurgery, 109 (1): 58-62 (2007). (IF = 1.506)
Vloeberghs E., Coen K., Van Dam D., De Deyn P.P. Validation of the APP23 model of Alzheimer´s disease through evaluation of risperidone treatment on aggressive behaviour. Arzneimittel - Forschung/Drug Res. In press Nov 9, 2007 (IF = 0.596)
Vloeberghs E., Van Dam D. , F. Franck, M. Staufenbiel, P.P. De Deyn. Mood and male sexual behaviour in the APP23 model of Alzheimer´s disease. Behav. Brain Res. 180: 146-151 (2007). (IF = 2.591)
Vloeberghs E., Van Dam D., Franck F., Serroyen J., Molenberghs G., Staufenbiel M, De Deyn P.P. Altered ingestive behaviour, weight changes and intact olfactory sense in an APP overexpression model. Behavioral Neuroscience In press (IF = 2.969)
Vroon A., Drukarch B., Bol J.G., Cras P., Brevé J.J., Allan S.M., Relton J.K., Hoogland P.V., Van Dam A.M., Neuroinflammation in Parkinson's patients and MPTP-treated mice is not restricted to the nigrostriatal system: microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb. Exp. Gerontol. 42( 8): 762-71 (2007). (IF = 1.439)
Wollmer M.A., K. Sleegers, M. Ingelsson, C. Zekanowski, N. Brouwers, A. Maruszak, F. Brunner, K.D. Huynh, L. Kilander, R.M. Brundin, M. Hedlund, V. Giedraitis, A. Glaser, S. Engelborghs, P.P. De Deyn, E. Kapaki, M. Tsolaki, M. Daniilidou, D. Molyva, G.P. Paraskevas, D.R. Thal, M. Barcikowska, J. Kuznicki, L. Lannfelt, C. Van Broeckhoven, R.M. Nitsch, C. Hock, A. Papassotiropoulos. Associated study of cholesterol-related genes in Alzheimer´s disease. Neurogenetics 8 (3): 179-188 (2007). (IF = 4.250)
Wostyn P., K. Audenaert, P.P. De Deyn. Alzheimer´s disease-related changes in diseases characterized by elevation of intracranial or intraocular pressure. Clin. Neurol. Neurosurg. 2007 Nov 29 (Epub ahead of print). (IF = 1.506)
Lijst van publicaties IBB in 2006
Achard P, De Schutter E (2006) Complex parameter landscape for a complex neuron model. PLoS Comput Biol. 2006 Jul 21, 2(7):e94 (no I.F.)
Bai Y., Ianokova E., Pu Q., Ghandour K., Levinson R., Martin J.-J., Ceuterick-de Groote C., Mazanec R., Seeman P., Shy M.E., Li J. R69C mutation in P0 gene alters myelination and ion channel subtype. Archives of Neurology, in press. (I.F. 4.900)
Baillieux H, De Smet HJ, Lesage G, Paquier P, De Deyn PP, Marien P. (2006) Neurobehavioral alterations in an adolescent following posterior fossa tumor resection. Cerebellum, 5: 289-295. (I.F. 1.762)
Bronnick K, Ehrt U, Emre M, De Deyn PP, Wesnes K, Tekin S, Aarsland D. (2006) Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease. J Neurol Neurosurg Psychiatry, 77: 1136-1142. (I.F. 3.122)
Brouns R, De Surgeloose D, Neetens I, De Deyn PP. (2006) Fatal venous cerebral air embolism secondary to a disconnected central venous catheter. Cerebrovasc Dis., 21: 212-214. (I.F. 2.319)
Brouwers N., Sleegers K., Engelborghs S., Bogaerts V., Serneels S., Kamali K., Corsmit E., De Leenheir E., Martin J.-J., De Deyn P.P., Van Broeckhoven C., Theuns J. (2006) Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease. Brain, 129: 2984-2991. (I.F. 7.535)
Brouwers N., Sleegers K., Engelborghs S., Bogaerts V., van Duijn C.M., De Deyn P.P., Van Broeckhoven C., Dermaut B. (2006) The UBQLN1 polymorphism, UBQ-8i, at 9q22 is not associated with Alzheimer´s disease with onset before 70 years. Neuroscience Letters, 392: 72-74. (I.F. 1.898)
Bruylant K, Crols R, Humbel RL, Appel B, De Deyn PP. (2006) Probably anti-Tr associated paraneoplastic cerebellar degeneration as initial presentation of a squamous cell carcinoma of the lung. Clin Neurol Neurosurg., 108: 415-417. (I.F. 1.089)
Burn D, Emre M, McKeith I, De Deyn PP, Aarsland D, Hsu C, Lane R.. (2006) Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson´s disease. Mov Disord., 21: 1899-1907. (I.F. 2.830)
Burns A, De Deyn PP. (2006) Risperidone for the treatment of neuropsychiatric features in dementia. Drugs Aging, 23: 887-896. (I.F. 2.072)
Cromphout K, Vleugels W, Heykants L, Schollen E, Keldermans L, Sciot R, D´Hooge R, De Deyn PP, von Figura K, Hartmann D, Korner C, Matthijs G. (2006) The normal phenotype of Pmm1-deficient mice suggests that Pmm1 is not essential for normal mouse development. Mol Cell Biol., 26: 5621-5635. (I.F. 7.093)
Cruts M., Gijselinck I., van der Zee J., Engelborghs S., Wils H., Pirici D., Rademakers R., Vandenberghe R., Dermaut B., Martin J.-J., van Duijn C., Peeters K., Sciot R., Santens P., De Pooter T., Mattheijssens M., Van den Broeck M., Cuijt I., Vennekens K., De Deyn P.P., Kumar-Singh S., Van Broeckhoven C. (2006) Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature, 442: 920-924. (I.F. 29.273)
De Deyn PP, Buitelaar J. (2006) Risperidone in the management of agitation and aggression associated with psychiatric disorders. Eur Psychiatry, 21: 21-28. (I.F. 1.273)
De Schutter E, Ascoli GA, Kennedy DN (2006) On the future of the Human Brain Project. Neuroinformatics 4: 129-130 (I.F. 3.902)
De Vriese A., Van Coster R., Smet J., Seneca S., Lovering A., Van Haute L.L., Vanopdenbosch L.J., Martin J.-J., Ceuterick-de Groote C., Vandecasteele S., Boelaert J.R. (2006) Linezolid-induced inhibition of mitochondrial protein synthesis. Clinical Infectious Diseases, 42: 1111-1117. (I.F. 6.510)
De Witte L, Wilssens I, Engelborghs S, De Deyn PP, Marien P. (2006) Impairment of syntax and lexical semantics in a patient with bilateral paramedian thalamic infarction. Brain Lang., 96: 69-77. (I.F. 2.129)
D'Hulst C., De Geest N., Reeve S.P., Van Dam D., De Deyn P.P., Hassan B.A., Kooy R.F. (2006) Decreased expression of the GABA(A) receptor in fragile X syndrome. Brain Research, 1121: 238-245. (I.F. 2.296)
Dierckx E., Engelborghs S., De Raedt R., De Deyn P.P., Ponjaert-Kristoffersen I. Differentiation between dementia and depression among older persons: can the difference between actual and premorbid intelligence be useful? International Psychogeriatrics, submitted. (I.F. 1.215)
Dierckx E., Engelborghs S., De Raedt R., Maertens K., De Deyn P.P., Ponjaert-Kristoffersen I. Differentiation between Mild Cognitive Impairment, Alzheimer´s disease and depression by means of cued recall. Psychological Medicine, 2006 Dec 13, Epub ahead of print. (I.F. 3.476)
Dierckx E., Engelborghs S., De Raedt R., Van Buggenhout M., De Deyn P.P., D´Haenens E., Ponjaert-Kristoffersen I. The 10-word learning task in the differential diagnosis of early Alzheimer´s disease and elderly depression. Journal of Clinical and Experimental Neuropsychology, submitted. (I.F. 1.689)
Elbaz A., Nelson L.M., Payami H., Ioannidis J.P., Fiske B.K., Annesi G., Carmine A., Factor S.A., Ferrarese C., Hadjigeorgiou G., Higgings D., Kawakami H., Krüger R., Marder K., Mayeux R., Mellick G.D., Nutt J., Ritz B., Samii A., Tanner C.M., Van Broeckhoven C., Van Den Eeden S.K., Wirdefeldt K., Zabetian C.P., Dehem M., Montimurro J.S., Myers R., Southwick A., Trikalinos T.A. (2006) Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. Lancet Neurology, 5: 917-923. (I.F. 11.231)
Engelborghs S., De Vreese K., Van de Casteele T., Vanderstichele H., Van Everbroeck B., Cras P., Martin J.J., Vanmechelen E., De Deyn P.P. Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia. Neurobiology of Aging, submitted. (I.F. 5.312)
Engelborghs S., Dermaut B., Mariën P., Symons A., Vloeberghs E., Maertens K., Somers N., Goeman J., Rademakers R., Van den Broeck M., Pickut B.A., Cruts M., Van Broeckhoven C., De Deyn P.P. (2006) Dose dependent effect of APOE 4 on behavioral symptoms in frontal lobe dementia patients. Neurobiology of Aging, 27: 285-292. (I.F. 5.312)
Engelborghs S., Maertens K., Mariën P., Vloeberghs E., Somers N., Nagels G., De Deyn P.P. (2006) Behavioural and neuropsychological correlates of frontal lobe features in dementia. Psychological Medicine, 36: 1173-1182. (I.F. 3.476)
Engelborghs S., Maertens K., Vloeberghs E., Aerts T., Somers N., Mariën P., De Deyn P.P. (2006) Neuropsychological and behavioural correlates of CSF biomarkers in dementia. Neurochemistry International, 48: 286-295. (I.F. 2.994)
Engelborghs S., Sleegers K., Cras P., Brouwers N., Serneels S., De Leenheir E., Martin J.-J., Vanmechelen E., Van Broeckhoven C., De Deyn P.P. No association of CSF biomarkers with APOE 4, plaque and tangle burden in definite Alzheimer´s disease. Brain, submitted. (I.F. 7.535)
Errijgers V, Van Dam D, Gantois I, Van Ginneken CJ, Grossman AW, D´Hooge R, De Deyn PP, Kooy F (2006) FVB.129P2-Pde6b(+) Tyr(c-ch)/Ant, a sighted variant of the FVB/N mouse strain suitable for behavioral analysis. Genes Brain Behav., 2006 Nov 3, Epub ahead of print. (I.F. 4.091)
Franken S, Wittke D, Mansson JE, D´Hooge R, De Deyn PP, Lullmann-Rauch R, Matzner U, Gieselmann V. (2006) Modest phenotypic improvements in ASA-deficient mice with only one UDP-galactose:ceramide-galactosyltransferase gene. Lipids Health Dis., 5:21. (no I.F.)
Gray LJ, Sprigg N, Bath PM, Sorensen P, Lindenstrom E, Boysen G, De Deyn PP, Friis P, Leys D, Marttila R, Olsson JE, O´Neill D, Ringelstein B, van der Sande JJ, Turpie AG; TAIST Investigators. (2006) Significant variation in mortality and functional outcome after acute ischaemic stroke between Western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST). J Neurol Neurosurg Psychiatry,.77: 327-333. (I.F. 3.122)
Hofmann UG, A Folkers, F. Mösch, T. Malina, K.M.L. Menne, G. Biella, P. Fagerstedt, E. De Schutter, W. Jensen, K. Yoshida, D. Hoehl, U. Thomas, M.G. Kindlundh, P. Norlin, M. de Curtis (2006) A novel high channel-count system for acute multi-site neuronal recordings. IEEE Transactions on Biomedical engineering 53: 1672-1677 (I.F. 1.857)
Irobi J, Dierick I, Jordanova A, Claeys KG, De Jonghe P, Timmerman V. (2006) Unraveling the genetics of distal hereditary motor neuronopathies. Neuromolecular Medicine, 8: 131-146. (I.F. 4.070)
Ivanova N., Löfgren A., Tournev I., Rousev R., Andreeva A., Jordanova A., Georgieva V., Deconinck T, Timmerman V., Kremensky I., De Jonghe P., Mitev V. (2006) Spastin gene mutations in Bulgarian patientswith hereditary spastic paraplegia. Clinical Genetics, 70: 490-495. (I.F. 3.276)
Kumar-Singh S., Theuns J., Van Broeck B., Pirici D., Vennekens K., Corsmit E., Cruts M., Dermaut B., Wang R., Van Broeckhoven C. (2006) Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Aβ42 and decreased Aβ40. Human Mutation, 27: 686-695. (I.F. 7.923)
Le Bastard N., Van Buggenhout M., de Leenheir E., Martin J.-J., De Deyn P.P., Engelborghs S. Low specificity limits the use of the cerebrospinal fluid A?1-42/P-tau181P ratio to discriminate Alzheimer´s disease from vascular dementia. Journal of Gerontology: Medical Sciences, in press. (I.F. 3.500)
Leergaard TB, Lillehaug S, De Schutter E, Bower JM, Bjaalie JG (2006) Topographical organization of pathways from somatosensory cortex through the pontine nuclei to tactile regions of the rat cerebellar hemispheres. European Journal of Neuroscience 24: 2801-2812 (I.F. 3.949)
Lupski J.R., Timmerman V. (2006) The CMT1A duplication: A historical perspective viewed from two sides of an ocean. In: Chapter 1 In: Genomic Disorders: The Genomic Basis of Disease Edited by J.R. Lupski and P. Stankiewicz (Humana Press, Totowa, N.J., USA.): 3-17. (no I.F.)
Marien P, Verhoeven J, Engelborghs S, Rooker S, Pickut BA, De Deyn PP. (2006) A role for the cerebellum in motor speech planning: evidence from foreign accent syndrome. Clin Neurol Neurosurg., 108: 518-522. (I.F. 1.089)
Miltenberger-Miltenyi G., Janecke A.R., Wanschitz J., Timmerman V., Windpassinger C., Auer-Grumbach M., Löscher W.L. : Clinical and electrophysiological features in CMT with mutations in the NEFL gene. Archives of Neurology, accepted for publication. (I.F. 4.900)
Nagels G. *, Engelborghs S. *, Vloeberghs E., Van Dam D., Pickut B.A., De Deyn P.P. (2006) Actigraphic measurement of agitated behaviour in dementia. International Journal of Geriatric Psychiatry, 21: 388-393 (* both first authors contributed equally to this paper). (I.F. 2.160)
Pals P., Bogaerts V., Rademakers R., De Pooter T., Bel Kacem S., Cruts M., Cras P., Van Broeckhoven C. Interaction between UCHL1 and pesticide exposure in Parkinson´s disease patients. Annals of Neurology, Submitted. (I.F. 7.571)
Pirici D., Vandenberghe R., Rademakers R., Dermaut B., Cruts M., Vennekens K., Cuijt I., Lubke U., Ceuterick C., Martin J.-J., Van Broeckhoven C., Kumar-Singh S. (2006) Characterization of ubiquitinated intraneuronal inclusions in a novel Belgian frontotemporal lobar degeneration family. Journal of Neuropathology and Experimental Neurology, 65: 289-301. (I.F. 4.471)
Rademakers R., Sleegers K., Pals P., Lohmann E., Durr A., Engelborghs S., De Pooter T., Van den Broeck M., Camuzat A., Nuytemans K., Pickut B., Cruts M., De Deyn P.P., Cras P., Brice A., Van Broeckhoven C. High density MAPT haplotyping in two independent Causasian PD associated samples implicates tau splicing in early-onset Parkinson's disease susceptibility. American Journal of Human Genetics (Under Review) (I.F. 12.649)
Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE, Abdalla M; 056 Study Group. (2006) Development of dyskinesias in a 5-year trial of ropinirole and L-dopa. Mov Disord., 21: 1844-1850. (I.F. 2.830)
Santamaria F. , Wils S, De Schutter E, Augustine GJ (2006) Anomalous diffusion in Purkinje cell dendrites caused by dendritic spines. Neuron 52: 635-648 (I.F. 14.304)
Sevin C., Benraiss A., Van Dam D., Bonnin D., Nagels G., Verot L., Laurendeau I., Vidaud M., Gieselmann V., Vanier M., De Deyn P.P., Aubourg P., Cartier N. (2006) Intracerebral adeno-associated virus-mediated gene transfer in rapidly progressive forms of metachromatic leukodystrophy. Human Molecular Genetics, 15: 53-64. (I.F. 7.764)
Sevin C., Verot L., Benraiss A., Van Dam D., Bonnin D., Nagels G., Fouquet F., Gieselmann V., Vanier M.T., De Deyn P.P., Aubourg P., Cartier N. (2006) Partial cure of established disease in an animal model of metachromatic leukodystrophy after intracerebral adeno-associated virus-mediated gene transfer. Gene Therapy, 2006 Nov 9; [Epub ahead of print]. (I.F. 4.836)
Sheorajpanday R, Slabbynck H, Van De Sompel W, Galdermans D, Neetens I, De Deyn PP. (2006) Small cell lung carcinoma presenting as collapsin response-mediating protein (CRMP) -5 paraneoplastic optic neuropathy. J Neuroophthalmol., 26: 168-172. (I.F. 0.976) Shin S-L, De Schutter E (2006) Dynamic synchronization of Purkinje cell simple spikes. Journal of Neurophysiology, 96: 3485-3491 (I.F. 3.853)
Solinas SMG, R. Maex, De Schutter (2006) Dendritic Amplification of Inhibitory Postsynaptic Potentials in a Model Purkinje Cell. European Journal of Neuroscience, 23: 1207-1218 (I.F. 3.949)
Sprigg N, Gray LJ, Bath PM, Boysen G, De Deyn PP, Friis P, Leys D, Marttila R, Olsson JE, O'Neill D, Ringelstein B, van der Sande JJ, Lindenstrom E; TAIST Investigators. (2006) Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trial. J Hypertens., 24: 1413-1417. (I.F. 5.218)
Theuns J., Brouwers N., Engelborghs S., Sleegers K., Bogaerts V., Corsmit E., De Pooter T., van Duijn C.M., De Deyn P.P., Van Broeckhoven C. (2006) Promoter mutations that increase amyloid precursor protein expression are associated with Alzheimer's disease. American Journal of Human Genetics, 78: 936-946. (I.F. 12.649)
Timmerman V., Lupski J.R. (2006) The CMT1A duplication and HNPP deletion. In: Chapter 11 In: Genomic Disorders: The Genomic Basis of Disease Edited by J.R. Lupski and P. Stankiewicz (Humana Press, Totowa, N.J., USA.): 169-178. (no I.F.)
Timmerman V., Lupski J.R., De Jonghe P. (2006) Molecular genetics, biology, and therapy for inherited peripheral neuropathies. Neuromolecular Medicine, 8: 1-2. (I.F. 4.070)
Torremans A., Marescau B., Kranzlin B., Gretz N., Billiouw J.M., Vanholder R., De Smet R., Bouwman K., Brouns R., De Deyn P.P. (2006) Biochemical validation of a rat model for polycystic kidney disease: comparison of guanidino compound profile with the human condition. Kidney International, 69: 2003-2012. (I.F. 4.927)
Van Broeck B., Vanhoutte G., Pirici D., Van Dam D., Wils H., Cuijt I., Vennekens K., Zabielski M., Michalik A., Theuns J., De Deyn P.P., Van der Linden A., Van Broeckhoven C., Kumar-Singh S. (2006) Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease. Neurobiology of Aging, 2006 Nov 15; [Epub ahead of print]. (I.F. 5.312)
Van Broeckhoven C., Kumar-Singh S. (2006) Genetics and pathology of alpha-secretase site APP mutations in the understanding of Alzheimer's disease. Journal of Alzheimer's Disease, 9: 389-398. (no I.F.)
Van Dam D, Lenders G, De Deyn PP. (2006) Effect of Morris water maze diameter on visual-spatial learning in different mouse strains. Neurobiol Learn Mem., 85: 164-172. (I.F. 4.091)
Van Dam D., De Deyn P.P. (2006) Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 model. European Neuropsychopharmacology, 16: 59-69. (I.F. 3.510)
Van Dam D., De Deyn P.P. (2006) Drug discovery in dementia: the role of rodent models. Nature Reviews Drug Discovery, 5: 956-970. (I.F. 18.775)
Van Den Bosch L, Timmerman V. (2006) Genetics of motor neuron disease. Current Neurology and Neuroscience Reports, 6: 423-431. (no I.F. )
van der Zee J., Rademakers R., Engelborghs S., Gijselinck I., Bogaerts V., Vandenberghe R., Santens P., Caekebeke J., De Pooter T., Peeters K., Lubke U., Van den Broeck M., Martin J.-J., Cruts M., De Deyn P.P., Van Broeckhoven C., Dermaut B. (2006) A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. Brain, 129: 841-852. (I.F. 7.535)
Van Everbroeck B., Michotte A., Sciot R., Godfraind C., Deprez M., Quoilin S., Martin J.-J., Cras P. (2006) Increased incidence of sporadic Creutzfeldt-Jakob disease in the age groups between 70 and 90 years in Belgium. European Journal of Epidemiology, 21: 443-447. (I.F. 1.361)
van Leeuwen F.W., van Tijn P., Sonnemans M.A., Hobo B., Mann D.M., Van Broeckhoven C., Kumar-Singh S., Cras P., Leuba G., Savioz A., Maat-Schieman M.L., Yamaguchi H., Kros J.M., Kamphorst W., Hol E.M., de Vos R.A., Fischer D.F. (2006) Frameshift proteins in autosomal dominant forms of Alzheimer disease and other tauopathies. Neurology, 66: S86-S92. (I.F. 5.056)
Verhoeven K., Claeys K., Züchner S., Schröder J.M., Ceuterick C., Jordanova A., Nelis E., De Vriendt E., Van Hul M., Seeman P., Mazanec R., Saifi M., Szigeti K., Mancia P., Butler I.J., Kochanski A., Ryniewicz B., De Bleecker J., Van den Bergh P., Verellen C., Van Coster R., Goemans N., Auerbach-Grumbach M., Robberecht W., Milic Rasic V., Nevo Y., Tournev I., Guergueltcheva V., Roelens F., Vieregge P., Vinci P., Moreno M.T., Christen H.J., Shy M.E., Lupski J.R., Vance J.M., De Jonghe P., Timmerman V. (2006) Mitofusin 2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain, 129: 2093-2102. (I.F. 7.535)
Verhoeven K., Timmerman V., Mauko B., Pieber T.R., De Jonghe P., Auer-Grumbach M. (2006) Recent advances in hereditary sensory and autonomic neuropathies. Current Opinion in Neurology, 19: 474-480. (I.F. 4.873)
Verpoorten N., Claeys K.G., Deprez L., Jacobs A., Van Gerwen V., Lagae L., Arts W.F., De Meirleir L., Ceuterick-de Groote C., De Jonghe P., Timmerman V., Nelis E. (2006) Novel frameshift and splice site mutations in the neurotrophic tyrosine kinase receptor type 1 gene (NTRK1) associated with hereditary sensory neuropathy type IV. Neuromuscular Disorders, 16: 19-25.(I.F. 3.340)
Verpoorten N., De Jonghe P., Timmerman V. (2006) Disease mechanisms in hereditary sensory and autonomic neuropathies. Neurobiology of Disease, 21: 247-255. (I.F. 4.048)
Verslegers WR, De Deyn PP. (2006) [Serious intoxication after inhaling methanol] Ned Tijdschr Geneeskd, 150: 2057. Dutch. No abstract available. (no I.F.)
Verslegers WR, Pickut BA, De Deyn PP. (2006) Paroxysmal neuralgic upper cervical pain attacks: the lower syndrome of cluster headache. Clin Neurol Neurosurg., 108: 737-743. (I.F. 1.089)
Vloeberghs E, Van Dam D, Coen K, Staufenbiel M, De Deyn PP. (2006) Aggressive male APP23 mice modeling behavioral alterations in dementia. Behav Neurosci. 120: 1380-1383. (I.F. 3.071)
Vloeberghs E., Van Dam D., D'Hooge R., Staufenbiel M., De Deyn P.P. (2006) APP23 mice display working memory impairment in the plus-shaped water maze. Neuroscience Letters, 407: 6-10. (I.F. 1.898)
Willekens BM, Rooker S, Dua G, Appel B, Martin JJ, Crols R, De Deyn PP. (2006) Central nervous system metastases of pulmonary adenocarcinoma mimicking neurofibromatosis type 2. Acta Neurol Belg., 106: 87-89. (I.F. 0.443)
Wouters M., De Laet A., Donck L.V., Delpire E., van Bogaert P.P., Timmermans J.P., de Kerchove d'Exaerde A., Smans K., Vanderwinden J.M. (2006) Active hybridization unravels a role for the ion cotransporter NKCC1 in the murine intestinal pacemaker. American Journal of Physiology. Gastrointestinal and Liver Physiology, 290: G1219-G1227. (I.F. 3.472)
Lijst van publicaties IBB in 2005
Belhocine T, Weiner SM, Brink I, De Deyn PP, Roland J, Van der Borght T, Flamen P. A plea for the elective inclusion of the brain in routine whole-body FDG PET. Eur J Nucl Med Mol Imaging. 2005 Mar;32(3):251-6. (I.F. 3.935)
Bitoun M, Maugenre S, Jeannet PY, Lacene E, Ferrer X, Laforet P, Martin JJ, Laporte J, Lochmuller H, Beggs AH, Fardeau M, Eymard B, Romero NB, Guicheney P (2005). Mutations in dynamin 2 cause dominant centronuclear myopathy. Nature Genetics 37: 1207-1209. (I.F. 24.695)
De Deyn P, Jeste DV, Swanink R, Kostic D, Breder C, Carson WH, Iwamoto T. Aripiprazole for the treatment of psychosis in patients with Alzheimer's disease: a randomized, placebo-controlled study. J Clin Psychopharmacol. 2005 Oct;25(5):463-7. (I.F. 4.419)
De Deyn PP*, Engelborghs S*, Saerens J, Goeman J, Marien P, Maertens K, Nagels G, Martin JJ, Pickut BA. The Middelheim Frontality Score: a behavioural assessment scale that discriminates frontotemporal dementia from Alzheimer´s disease. Int J Geriatr Psychiatry. 2005 Jan;20(1):70-9 (* both first authors contributed equally to this work). (I.F. 1.971)
De Deyn PP, Katz IR, Brodaty H, Lyons B, Greenspan A, Burns A. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone. Clin Neurol Neurosurg. 2005 Oct;107(6):497-508. (I.F. 0.954)
De Paepe B, De Keyzer K, Martin JJ, De Bleecker JL (2005). Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies. Acta Neuropathol (Berl) 109: 576-582. (I.F. 2.503)
Eloot S, Torremans A, De Smet R, Marescau B, De Wachter D, De Deyn PP, Lameire N, Verdonck P, Vanholder R. Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds. Kidney Int. 2005 Apr;67(4):1566-75. (I.F. 4.790)
Engelborghs S, Maertens K, Nagels G, Vloeberghs E, Marien P, Symons A, Ketels V, Estercam S, Somers N, De Deyn PP. Neuropsychiatric symptoms of dementia: cross-sectional analysis from a prospective, longitudinal Belgian study. Int J Geriatr Psychiatry. 2005 Nov;20(11):1028-37. (I.F. 1.971)
Hakonen, A.H., Heiskanen,S., Juvonen,V., Lappalainen,I., Luoma,P.T., Rantamäki,M., Van Goethem,G., Löfgren,A., Hackman,P., Paetau,A., Kaakkola,S., Majamaa,K., Varilo,T., Udd,B., Kääriäinen,H., Bindoff,L.A., Suomalainen,A.: Mitochondrial DNA polymerase W748S mutation: A new common cause of autosomal recessive ataxia with ancient European origin. American Journal of Human Genetics (Accepted for Publication) (I.F.: 12.34)
Jorens PG, Parizel PM, Demey HE, Smets K, Jadoul K, Verbeek MM, Wevers RA, Cras P (2005) Meningoencephalitis caused by Streptococcus pneumoniae: a diagnostic and therapeutic challenge Diagnosis with diffusion-weighted MRI leading to treatment with corticosteroids. Neuroradiology 47(10):758-64. (I.F. 1.515)
Kumar-Singh,S., Dickson,D., Pirici,D.N., Serneels,S., Ceuterick,C., McGowan,E., Duff,K., Hardy,J., Van Broeckhoven,C.: Dense-core plaques in Alzheimer´s mice are derived from vascular walls. American Journal of Pathology 167(2): 527-543 (2005) (I.F.: 6.441)
Laing NG, Ceuterick-de Groote C, Dye DE, Liyanage K, Duff RM, Dubois B, Robberecht W, Sciot R, Martin JJ, Goebel HH (2005). Myosin storage myopathy: slow skeletal myosin (MYH7) mutation in two isolated cases. Neurology 64: 527-529. (I.F. 5.973) Mariën P, Abutalebi J, Engelborghs S, De Deyn PP. Pathophysiology of language switching and mixing in an early bilingual child with subcortical aphasia. Neurocase. 2005 Dec;11(6):385-98. (I.F. 0.978)
Mariën P, Brouns R, Engelborghs S, Wackenier P, Verhoeven J, Ceulemans B, De Deyn PP. Cerebellar cognitive affective syndrome in two relatives with Gillespie syndrome. Cortex, in press. (I.F. 2.472)
Nagels G, Geentjens L, Kos D, Vleugels L, D'hooghe MB, Van Asch P, Vuylsteke K, De Deyn PP. Paced visual serial addition test in multiple sclerosis. Clin Neurol Neurosurg. 2005 Apr;107(3):218-22. (I.F. 0.954)
Niessen P., Rensen S., van Deursen J., De Man J., De Laet A.,Vanderwinden J.-M., Wedel T., Baker D., Doevendans P., Hofker M.,Gijbels M., van Eys G. Smoothelin-A is essential for functional intestinal smooth muscle contractility in mice. Gastroenterology 129(5):1592-1601 (2005). (I.F. 13.092)
Petersen RB, Siedlak SL, Lee HG, Kim YS, Nunomura A, Tagliavini F, Ghetti B, Cras P, Moreira PI, Castellani RJ, Guentchev M, Budka H, Ironside JW, Gambetti, P, Smith MA, Perry G. (2005) Redox metals and oxidative abnormalities in human prion diseases. Acta Neuropathol (Berl) 110(3):232-8. (I.F. 2.503)
Pirici D, van der Zee J, Rademakers R, Dermaut B, Cruts M, Lübke U, Ceuterick C, Martin J-J, Vandenberghe R, Van Broeckhoven C, Kumar-Singh S. Clinical, genetic and neuropathological description of a Belgian FTD family with ubiquitin-positive, tau-negative inclusions (FTD-U). Accepted in J Neuropathol Exp Neurol. (I.F. 5.037)
Pittoors F., van Bogaert P.P. "Inactivation" of mHCN2 expressed in oocytes. Eur J Physiology 449: R7 (2005). Rabinowitz J, Davidson M, De Deyn PP, Katz I, Brodaty H, Cohen-Mansfield J. Factor analysis of the Cohen-Mansfield Agitation Inventory in three large samples of nursing home patients with dementia and behavioral disturbance. Am J Geriatr Psychiatry. 2005 Nov;13(11):991-8. (I.F.: 3.469)
Rademakers,R., Melquist,S., Cruts,M., Theuns,J., Del-Favero,J., Poorkaj,P., Baker,M., Sleegers,K., Crook,R., De Pooter,T., Bel Kacem,S., Adamson,J., Van den Bossche,D., Van den Broeck,M., Gass,J., Corsmit,E., De Rijk,P., Thomas,N., Engelborghs,S., Heckman,M., Crook,J., De Deyn,P.P., Dickson,D., Schellenberg,G., Van Broeckhoven,C., Hutton,M.L.: High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Human Molecular Genetics 14(21): 3281-3292 (2005) (I.F.: 7.801)
Rademakers,R., Sleegers,K., Pals,P., Lohmann,E., Durr,A., Engelborghs,S., De Pooter,T., Van den Broeck,M., Camuzat,A., Nuytemans,K., Pickut,B., Cruts,M., De Deyn,P.P., Cras,P., Brice,A., Van Broeckhoven,C.: High density MAPT haplotyping in two independent Causasian PD associated samples implicates tau splicing in early-onset Parkinson´s disease susceptibility. American Journal of Human Genetics (Under Review) (I.F.: 12.34)
Robert PH, Verhey FR, Byrne EJ, Hurt C, De Deyn PP, Nobili F, Riello R, Rodriguez G, Frisoni GB, Tsolaki M, Kyriazopoulou N, Bullock R, Burns A, Vellas B. Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium. Eur Psychiatry. 2005 Nov;20(7):490-6. Epub 2005 Jan 27. (I.F.: 1.191)
Sindic CJ, Seeldrayers P, Vande Gaer L, De Smet E, Nagels G, De Deyn PP, Medaer R, Guillaume D, D'Hooghe MB, Deville MC, Decoo D, Sadzot B, Van Landegem W, Strauven T, Pepin J, Merckx H, Caekebeke J, van der Tool MA. Long-term follow up of glatiramer acetate compassionate use in Belgium. Acta Neurol Belg. 2005 Jun;105(2):81-5. (I.F.: 0.380)
Smets K, R. salgado, P.J. Simons, R. Declercq, K. De Smedt, P. Cras (2005) Central neurocytoma presenting with intraventricular hemorrhage: case report and review of the litterature. Acta Neurol Belg 105: 218-225. (I.F.: 0.380)
Torremans A, Marescau B, Possemiers I, Van Dam D, D'Hooge R, Isbrandt D, De Deyn PP. Biochemical and behavioural phenotyping of a mouse model for GAMT deficiency. J Neurol Sci. 2005 Apr 15;231(1-2):49-55. (I.F.: 2.366)
Torremans A, Marescau B, Van Dam D, Van Ginneken C, Van Meir F, Van Bogaert PP, D'Hooge R, de Vente J, De Deyn PP. GSA: behavioral, histological, electrophysiological and neurochemical effects. Physiol Behav. 2005 Feb 15;84(2):251-64. (I.F.: 2.044)
Van Dam D, Abramowski D, Staufenbiel M, De Deyn PP. Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model. Psychopharmacology (Berl). 2005 Jun;180(1):177-90. (I.F.: 3.146)
Van Dam D, Errijgers V, Kooy RF, Willemsen R, Mientjes E, Oostra BA, De Deyn PP. Cognitive decline, neuromotor and behavioural disturbances in a mouse model for fragile-X-associated tremor/ataxia syndrome (FXTAS). Behav Brain Res. 2005 Jul 30;162(2):233-9. (I.F.: 2.992)
Van Dam D, Marescau B, Cremers T, Mulder J, Engelborghs S, De Deyn PP. Regional distribution of biogenic amines, amino acids and cholinergic markers in the CNS of the C57BL/6 strain. Amino Acids. 2005 Jun;28(4):377-87. Epub 2005 May 17. (I.F.: 2.000)
Van Dam D, Marescau B, Engelborghs S, Cremers T, Mulder J, Staufenbiel M, De Deyn PP. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models. Neurochem Int. 2005 Apr;46(5):409-22. (I.F.: 3.211)
Van Dam D, Vloeberghs E, Abramowski D, Staufenbiel M, De Deyn PP. APP23 mice as a model of Alzheimer's disease: an example of a transgenic approach to modeling a CNS disorder. CNS Spectr. 2005 Mar;10(3):207-22. Review.
Van Everbroeck B, Boons J, Cras P. (2005) 14-3-3 {gamma}-isoform detection distinguishes sporadic Creutzfeldt-Jakob disease from other dementias. J Neurol Neurosurg Psychiatry 76(1):100-2. (I.F.: 3.110)
Van Everbroeck, B., J. Boons, P. Cras (2005) Cerebrospinal fluid markers in Creutzfeldt-Jakob´s disease. Clin Neurol Neurosurg 107(5):355-60. (I.F.: 0.954)
Vellas B, Cunha L, Gertz HJ, De Deyn PP, Wesnes K, Hammond G, Schwalen S; GAL-INT-28 Study Group. Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease. Curr Med Res Opin. 2005 Sep;21(9):1423-9. (I.F.: 2.928)
Verhoeven J, Mariën P, Engelborghs S, D´Haenen H, De Deyn PP. A foreign speech accent in a case of conversion disorder. Behav Neurol, in press. (I.F.: 1.158)
Verpoorten N, Verhoeven K, Weckx S, Jacobs A, Serneels S, Del Favero J, Ceuterick C, Van Bockstaele DR, Berneman ZN, Jordaens K, Van Den Bosch L, Robberecht W, Nobbio L, Schenone A, Dessaud E, deLapeyrière O, Huylebroeck D, Zwijsen A, De Jonghe P, Timmerman V (2005). Synpatopodin and 4 novel genes identified in primary sensory neurons. Molecular and Cellular Neuroscience 30: 316-325. (I.F.: 3.789)
Verpoorten,N., Claeys,K.G., Deprez,L., Jacobs,A., Van Gerwen,V., Lagae,L., Arts,W.F., De Meirleir,L., Ceuterick,C., De Jonghe,P., Timmerman,V., Nelis,E.: Novel frameshift and splice site mutations in the neurotrophic tyrosine kinase receptor type 1 gene (NTRK1) associated with hereditary sensory neuropathy type IV. Neuromuscular Disorders (Accepted for Publication) (I.F.: 3.042)
Verpoorten,N., Verhoeven,K., Weckx,S., Jacobs,A., Serneels,S., Del-Favero,J., Ceuterick,C., Van Bockstaele,D.R., Berneman,Z.N., Jordaens,K., Van Den Bosch,L., Robberecht,W., Nobbio,L., Schenone,A., Dessaud,E., deLapeyrière,O., Huylebroeck,D., Zwijsen,A., De Jonghe,P., Timmerman,V.: Synaptopodin and 4 novel genes identified in primary sensory neurons. Molecular and Cellular Neuroscience 30(3): 316-325 (2005) (I.F.: 3.789)
Wouters M., De Laet A., Ver Donck L., Delpire L., Van Bogaert P.P., Timmermans J.-P., de Kerchove d´Exaerde A., Smans K., Vanderwinden J.-M. Subtractive hybridization unravels a role for the ion co-transporter NKCC1 in the murine intestinal pacemaker. American J Physiology-Gastrointestinal and Liver Physiology ( abstract on line beschikbaar August 25,2005; in press). (I.F.: 3.479)
Wuyts W, Reyniers E, Ceuterick C, Storm K, de Barsy T, Martin JJ (2005). Myopathy and phosphorylase kinase deficiency caused by a mutation in the PHKA1 gene. Am J Med Genet A. 133A: 82-84. (I.F.: 3.659)